Onderneming Agios Pharmaceuticals, Inc.
Aandelen
AGIO
US00847X1046
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
29,6 USD | +1,98% | -3,56% | +32,64% |
16/02 | AGIOS PHARMACEUTICALS, INC. : Een koopadvies van RBC Capital Markets | ZM |
15/02 | Agios Pharmaceuticals, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 385
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Medicines for Cellular Metabolism
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +88,36% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +88,36% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 08-08-22 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 26-09-22 |
Jacqualyn Fouse
CHM | Chairman | 62 | 05-12-17 |
Sarah Gheuens
CTO | Chief Tech/Sci/R&D Officer | 45 | 01-12-19 |
Clive Patience
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-06-17 |
Investor Relations Contact | - | - | |
Charlie Newman
PRN | Corporate Officer/Principal | - | 01-01-22 |
Ellen Lopresti
HRO | Human Resources Officer | - | 01-01-17 |
T. Washburn
AUD | Comptroller/Controller/Auditor | 43 | - |
Tsveta Milanova
PRN | Corporate Officer/Principal | 47 | 03-01-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 01-06-23 |
Director/Board Member | 64 | 09-12-14 | |
May Kin Ho
BRD | Director/Board Member | 71 | 23-06-15 |
Jacqualyn Fouse
CHM | Chairman | 62 | 05-12-17 |
David Scadden
BRD | Director/Board Member | 71 | 27-05-17 |
Brian Goff
CEO | Chief Executive Officer | 55 | 08-08-22 |
Cynthia Smith
BRD | Director/Board Member | 55 | 11-08-22 |
Rahul Ballal
BRD | Director/Board Member | 46 | 11-08-22 |
Catherine Owen
BRD | Director/Board Member | - | 13-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 72 411 258 | 55 286 424 ( 76,35 %) | 16 216 411 ( 22,39 %) | 76,35 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,64% | 1,63 mld. | |
-3,33% | 102 mld. | |
+2,24% | 96,84 mld. | |
-0,44% | 21,48 mld. | |
-18,51% | 20,82 mld. | |
-7,45% | 18,6 mld. | |
-40,31% | 16,81 mld. | |
-26,30% | 13,78 mld. | |
+0,49% | 13,4 mld. | |
+20,81% | 11,06 mld. |
- Beurs
- Aandelen
- Koers AGIO
- Onderneming Agios Pharmaceuticals, Inc.